Hydralazine/isosorbide dinitrate (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hydralazine/isosorbide dinitrate" in English language version.

refsWebsite

Global rank English rank

6doi.org

2^nd place

6nih.gov

4^th place

5web.archive.org

1^st place

2google.com

163^rd place

185^th place

2semanticscholar.org

11^th place

8^th place

2sciam.com

6,119^th place

6,509^th place

2fda.gov

447^th place

338^th place

1mit.edu

415^th place

327^th place

1bionews.org.uk

low place

1books.google.com

3^rd place

1ancecardio.it

low place

1archive.org

6^th place

1wnyc.org

4,892^nd place

2,749^th place

1scientificamerican.com

896^th place

674^th place

1harvard.edu

18^th place

17^th place

1fdaweb.com

low place

1healthaffairs.org

low place

ancecardio.it

Adams KF, Lindenfeld JA, Arnold JM, Baker DW, Barnard DH, Baughman KL, et al. (February 2006). "HFSA 2006 comprehensive heart failure practice guideline" (PDF). Journal of Cardiac Failure. 12 (1): e1-22. doi:10.1016/j.cardfail.2005.11.005. PMID 16500560. Archived from the original (PDF) on 28 July 2011.

archive.org

Roberts D (2011). "Chapter 8: The Color Coded Pill". Fatal Invention: How Science, Politics, and Big Business Re-create Race in the Twenty-first Century. New York: The New Press. ISBN 978-1-595-58834-0.

bionews.org.uk

Whitmarsh I, Jones DS, eds. (2010). "Governance and the Uses of Race" (PDF). What's the Use of Race?: Modern Governance and the Biology of Difference. Cambridge, MA: MIT Press. ISBN 978-0-262-51424-8. Archived from the original (PDF) on 5 March 2016. Retrieved 8 December 2013.* Panizzo R (21 November 2011). "Book Review: What's the Use of Race? Modern Governance and the Biology of Difference". BioNews. No. 634.

books.google.com

Kahn J. "Chapter 7: BiDil and Racialized Medicine". In Krimsky S, Sloan K (eds.). Race and the Genetic Revolution: Science, Myth, and Culture. Columbia University Press. doi:10.7312/krim15696-008. ISBN 978-0-231-52769-9.

doi.org

Ferdinand KC, Elkayam U, Mancini D, Ofili E, Piña I, Anand I, et al. (July 2014). "Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial". The American Journal of Cardiology. 114 (1): 151–159. doi:10.1016/j.amjcard.2014.04.018. PMID 24846808.
Kahn J. "Chapter 7: BiDil and Racialized Medicine". In Krimsky S, Sloan K (eds.). Race and the Genetic Revolution: Science, Myth, and Culture. Columbia University Press. doi:10.7312/krim15696-008. ISBN 978-0-231-52769-9.
Exner DV, Dries DL, Domanski MJ, Cohn JN (May 2001). "Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction". The New England Journal of Medicine. 344 (18): 1351–1357. doi:10.1056/NEJM200105033441802. PMID 11333991.
Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R, Ferdinand K, et al. (November 2004). "Combination of isosorbide dinitrate and hydralazine in blacks with heart failure". The New England Journal of Medicine. 351 (20): 2049–2057. doi:10.1056/NEJMoa042934. PMID 15533851. S2CID 12012042.
Adams KF, Lindenfeld JA, Arnold JM, Baker DW, Barnard DH, Baughman KL, et al. (February 2006). "HFSA 2006 comprehensive heart failure practice guideline" (PDF). Journal of Cardiac Failure. 12 (1): e1-22. doi:10.1016/j.cardfail.2005.11.005. PMID 16500560. Archived from the original (PDF) on 28 July 2011.
Kahn J (1 August 2007). "Race in a Bottle". Scientific American. 297 (2): 40–45. Bibcode:2007SciAm.297b..40K. doi:10.1038/scientificamerican0807-40. S2CID 119514435. Article criticizing approval of Bidil.

fda.gov

accessdata.fda.gov

"Bidil (Isosorbide Dinitrate and Hydralazine Hydrochloride) Tablets". Drug Approval Package. U.S. Food and Drug Administration.

fda.gov

"FDA Approves BiDil Heart Failure Drug for Black Patients". U.S. Food and Drug Administration. 23 June 2005. Archived from the original on 8 July 2005.

fdaweb.com

"Response for FDA's Robert Temple to Scientific American article". FDA Web Review.

google.com

US 4868179, Cohn JN, "Method of reducing mortality associated with congestive heart failure using hydralazine and isosorbide dinitrate", issued 19 September 1989, assigned to Department of Veterans Affairs
US 6465463, Cohn JN, Carson P, "Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate", issued 15 October 2002, assigned to Nitromed Inc. and Arbor Pharmaceuticals LLC

harvard.edu

ui.adsabs.harvard.edu

Kahn J (1 August 2007). "Race in a Bottle". Scientific American. 297 (2): 40–45. Bibcode:2007SciAm.297b..40K. doi:10.1038/scientificamerican0807-40. S2CID 119514435. Article criticizing approval of Bidil.

healthaffairs.org

content.healthaffairs.org

Puckrein G (2006). "BiDil: From Another Vantage Point". Health Affairs. Archived from the original on 22 March 2015. Retrieved 1 October 2013.

mit.edu

mitpress.mit.edu

Whitmarsh I, Jones DS, eds. (2010). "Governance and the Uses of Race" (PDF). What's the Use of Race?: Modern Governance and the Biology of Difference. Cambridge, MA: MIT Press. ISBN 978-0-262-51424-8. Archived from the original (PDF) on 5 March 2016. Retrieved 8 December 2013.* Panizzo R (21 November 2011). "Book Review: What's the Use of Race? Modern Governance and the Biology of Difference". BioNews. No. 634.

nih.gov

pubmed.ncbi.nlm.nih.gov

Ferdinand KC, Elkayam U, Mancini D, Ofili E, Piña I, Anand I, et al. (July 2014). "Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial". The American Journal of Cardiology. 114 (1): 151–159. doi:10.1016/j.amjcard.2014.04.018. PMID 24846808.
Exner DV, Dries DL, Domanski MJ, Cohn JN (May 2001). "Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction". The New England Journal of Medicine. 344 (18): 1351–1357. doi:10.1056/NEJM200105033441802. PMID 11333991.
Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R, Ferdinand K, et al. (November 2004). "Combination of isosorbide dinitrate and hydralazine in blacks with heart failure". The New England Journal of Medicine. 351 (20): 2049–2057. doi:10.1056/NEJMoa042934. PMID 15533851. S2CID 12012042.
Adams KF, Lindenfeld JA, Arnold JM, Baker DW, Barnard DH, Baughman KL, et al. (February 2006). "HFSA 2006 comprehensive heart failure practice guideline" (PDF). Journal of Cardiac Failure. 12 (1): e1-22. doi:10.1016/j.cardfail.2005.11.005. PMID 16500560. Archived from the original (PDF) on 28 July 2011.

dailymed.nlm.nih.gov

"Bidil- hydralazine hydrochloride and isosorbide dinitrate tablet, film coated". DailyMed. U.S. National Library of Medicine. 26 January 2021. Retrieved 11 April 2022.

ncbi.nlm.nih.gov

Carson P, et al. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group J Card Fail. 1999 Sep;5(3):178-87.

sciam.com

Kahn J (1 August 2007). "Race in a Bottle". Scientific American. 297 (2): 40–45. Bibcode:2007SciAm.297b..40K. doi:10.1038/scientificamerican0807-40. S2CID 119514435. Article criticizing approval of Bidil.
"BiDil Maker NitroMed Responds to "Race In A Bottle" The Science Behind BiDil". Scientific American. 30 July 2007.

scientificamerican.com

"Race-Based Medicine: A Recipe for Controversy". Scientific American. 31 July 2007.

semanticscholar.org

api.semanticscholar.org

Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R, Ferdinand K, et al. (November 2004). "Combination of isosorbide dinitrate and hydralazine in blacks with heart failure". The New England Journal of Medicine. 351 (20): 2049–2057. doi:10.1056/NEJMoa042934. PMID 15533851. S2CID 12012042.
Kahn J (1 August 2007). "Race in a Bottle". Scientific American. 297 (2): 40–45. Bibcode:2007SciAm.297b..40K. doi:10.1038/scientificamerican0807-40. S2CID 119514435. Article criticizing approval of Bidil.

web.archive.org

Whitmarsh I, Jones DS, eds. (2010). "Governance and the Uses of Race" (PDF). What's the Use of Race?: Modern Governance and the Biology of Difference. Cambridge, MA: MIT Press. ISBN 978-0-262-51424-8. Archived from the original (PDF) on 5 March 2016. Retrieved 8 December 2013.* Panizzo R (21 November 2011). "Book Review: What's the Use of Race? Modern Governance and the Biology of Difference". BioNews. No. 634.
"FDA Approves BiDil Heart Failure Drug for Black Patients". U.S. Food and Drug Administration. 23 June 2005. Archived from the original on 8 July 2005.
Adams KF, Lindenfeld JA, Arnold JM, Baker DW, Barnard DH, Baughman KL, et al. (February 2006). "HFSA 2006 comprehensive heart failure practice guideline" (PDF). Journal of Cardiac Failure. 12 (1): e1-22. doi:10.1016/j.cardfail.2005.11.005. PMID 16500560. Archived from the original (PDF) on 28 July 2011.
"Race and Medicine". Radiolab. WNYC. 28 November 2008. Archived from the original on 31 January 2009. Audio story about racial issues surrounding Bidil.
Puckrein G (2006). "BiDil: From Another Vantage Point". Health Affairs. Archived from the original on 22 March 2015. Retrieved 1 October 2013.

wnyc.org

"Race and Medicine". Radiolab. WNYC. 28 November 2008. Archived from the original on 31 January 2009. Audio story about racial issues surrounding Bidil.